3 completed. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
Follow Dr. Amjad Khan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clostridium Butyricum CBM588® vs. Rifaximin for Symptomatic Uncomplicated Diverticular Disease (SUDD): A Real-World Retrospective Study Clostridium butyricum CBM588® (Butirrisan®), Rifaximin 400 mg Oral Tablet - Diverticular Diseases, Gastro-Intestinal Disorder | Not applicable | Completed | Dr. Amjad Khan | 70 | 2023-03-01 | 2025-05-18 |
| Natural Topical Treatment for Vulvar and Vaginal Atrophy Zantogin® Gel - Genitourinary Syndrome of Menopause | Completed | Dr. Amjad Khan | 50 | 2022-01-05 | 2023-11-13 | |
| Study to Investigate the Treatment Benefit of Probiotic Lactobacillus Crispatus M247 in Women Undergoing Homologous Level 2 Assisted Reproductive Technology (ART) Procedures Probiotic Lactobacillus crispatus M247 - Fertility Issues | Not applicable | Completed | Dr. Amjad Khan | 160 | 2020-01-10 | 2023-11-13 |
Digestive System Diseases (1) · Diverticular Diseases (1) · Infertility (1)
Italy (3)